| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736474A Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof |
| 02/22/2006 | CN1736447A Compound essential oil for treating prostatitis |
| 02/22/2006 | CN1736445A Kidney-tonifying brain-invigorating medicine and preparation process thereof |
| 02/22/2006 | CN1736444A Formulation with six ingredients containing rehmanniae |
| 02/22/2006 | CN1736440A Application of peru apple in preparation of medicine |
| 02/22/2006 | CN1736396A Compound lycopene formulation for men and preparation process thereof |
| 02/22/2006 | CN1736381A Use of morpholine methyltetralone in preparation of smooth muscles spasmolytic |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/22/2006 | CN1242802C Chinese herbal medicinal compound preparation for treating lithangiuria and gallstones |
| 02/22/2006 | CN1242795C Chinese traditional medicine for treating prostate disease |
| 02/21/2006 | US7002018 Process for the preparation of amorphous form of torsemide |
| 02/21/2006 | US7001920 Psychological disorders; antidepressant |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001602 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2152486C Anticonvulsant sorbopyranose sulfamates |
| 02/16/2006 | WO2006017650A2 Iron chelators for treating radiocontrast-associated renal dysfunction |
| 02/16/2006 | WO2006016245A1 Muscarinic receptor antagonists |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035959 e.g. (dibenzofuran-4-yl)-(3,5-dichlorophenylamino)acetic acid; glycine B antagonist on the NMDA receptor complex for regulating the calcium balance; analgesic,antiinflammatory, antidepressant, anxiolytic agent, neurodegenerative diseases; chronic and neuropathic pain |
| 02/16/2006 | US20060035923 Overactive bladder treating drug |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035209 Screening method |
| 02/16/2006 | CA2576190A1 Iron chelators for treating radiocontrast-associated renal dysfunction |
| 02/16/2006 | CA2575849A1 Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1624877A2 Use of steroid derivatives for the treatment of angiotensin ii related diseases e.g. cardiovascular and proliferative disorders |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733279A Medicine composition for treating chronic renal failure |
| 02/15/2006 | CN1733277A Health caring wine for strengthening kidney and enhancing energy |
| 02/15/2006 | CN1733273A Pulean pharmaceutical preparation, process for preparing the same and quality controlling method thereof |
| 02/15/2006 | CN1733272A Pulean pharmaceutical preparation for treating urinary system diseases and process for preparing the same |
| 02/15/2006 | CN1733261A Capsule for curing uremia |
| 02/15/2006 | CN1733197A Medicine for curing chronic prostatitis and process for preparing the same |
| 02/15/2006 | CN1733155A Urinary calculus removal Chinese traditional medicine composition and process for preparing the same |
| 02/15/2006 | CN1733143A Aimal liver concentration tablet and technique for preparing the same |
| 02/15/2006 | CN1733033A Acanthopanax dripping pills and its preparation process |
| 02/15/2006 | CN1733003A Oral liquor with pollen and preparation method thereof |
| 02/15/2006 | CN1732998A Process for preparing film coated brain-invigorating kidney-tonifying pills |
| 02/15/2006 | CN1732984A Concentrated tablet of animal kidney and technique for preparing the same |
| 02/15/2006 | CN1732957A Medicine-containing soft capsule and its preparation method |
| 02/15/2006 | CN1732956A Pharmaceutical soft capsule containing finasteride |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241646C Improvement in or relating to endometrial function |
| 02/15/2006 | CN1241610C Medicinal composition for preventing and curing prostatitis and hyperplasia of prostate and its preparing method |
| 02/15/2006 | CN1241596C Oral Chinese traditional medicine preparation for treating cystitis |
| 02/15/2006 | CN1241556C Emodin injection preparation and its preparation method |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 02/14/2006 | US6998395 Controlled release formulation for preventing or treating risk factors for cardiovascular disease |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2378533C Erythropoietin conjugates with polyethylenglycol |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/09/2006 | WO2006014864A2 Methods and compositions for reducing c-reactive protein |
| 02/09/2006 | WO2006013873A1 Drugs having cyclooxygenase inhibiting activity |
| 02/09/2006 | WO2006013420A2 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 02/09/2006 | US20060030622 Compounds and methods for the treatment of urogenital disorders |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060029605 Use of ErbB receptor ligands in treating diabetes |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2612149A1 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy(bph) |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623740A1 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1622906A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 02/08/2006 | EP1622611A1 Imidazolin-2-ylaminophenyl amides as ip antagonists |
| 02/08/2006 | EP1622606A1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 02/08/2006 | EP1622604A1 Bicalutamide forms, compositions, and processes thereof |
| 02/08/2006 | EP1622564A2 Diazabicyclononene derivatives |
| 02/08/2006 | EP1622450A2 Method for promoting uninterrupted sleep by administration of trospium chloride |
| 02/08/2006 | EP1309328A4 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 02/08/2006 | EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1730091A Medicine for curing lithangiuria |
| 02/08/2006 | CN1730085A Drop pill for treating hematuresis and process for preparing the same |